Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency

相似書籍

• Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study
  由: Cowan, Juthaporn, et al.
  出版: (2020)
• Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study
  由: Anderson, John T., et al.
  出版: (2021)
• Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
  由: Kanegane, Hirokazu, et al.
  出版: (2014)
• Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
  由: Hagan, John B., et al.
  出版: (2010)
• Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study
  由: van Schaik, Ivo N., et al.
  出版: (2019)